A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer
Clinical trial NCT06292689 · RECRUITING
Trial details
- NCT number
- NCT06292689
- Sponsor
- Zhejiang Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-22
- Primary completion
- 2026-03-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.